Patients Treated With Cancer Drug For Macular Degeneration Experience Problems

Friday, December 5, 2008

Comments

canadaeast.com

Public health authorities in Canada are investigating a spike in cases of eye inflammation among patients being treated for macular degeneration with the cancer drug Avastin.

Full Story

Retina Products and Equipment »

After permanent punctal occlusion with cautery:
1. 5-10% rate of recanalization is expected.
2. 10-20% rate of recanalization is expected.
3. 20-30% rate of recanalization is expected.
4. 30-40% rate of recanalization is expected.
Check The Answer